ORIC
ORIC Pharmaceuticals, Inc. Healthcare - Biotechnology Investor Relations →
ORIC Pharmaceuticals, Inc. (ORIC) closed at $10.42 as of 2026-02-02, trading 34.1% above its 200-week moving average of $7.77. The stock moved further from the line this week, up from 32.5% last week. The 14-week RSI sits at 38, indicating neutral momentum.
Over the past 254 weeks of data, ORIC has crossed below its 200-week moving average 3 times. On average, these episodes lasted 70 weeks. The average one-year return after crossing below was -63.4%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1015 million, ORIC is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -39.7%. The stock trades at 2.5x book value.
Share count has increased 80.1% over three years, indicating dilution.
Over the past 5 years, a hypothetical investment of $100 in ORIC would have grown to $45, compared to $187 for the S&P 500. ORIC has returned -14.8% annualized vs 13.3% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: ORIC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ORIC Crosses Below the Line?
Across 3 historical episodes, buying ORIC when it crossed below its 200-week moving average produced an average return of -35.7% after 12 months (median -65.0%), compared to +13.7% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was -75.0% vs +6.0% for the index.
Each line shows $100 invested at the moment ORIC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ORIC has crossed below its 200-week MA 3 times with an average 1-year return of +-63.4% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2021 | Feb 2024 | 152 | 86.9% | -71.6% | -55.1% |
| Mar 2024 | Jan 2025 | 43 | 43.8% | -55.3% | -24.2% |
| Feb 2025 | Jun 2025 | 16 | 45.6% | N/A | +24.6% |
| Average | 70 | — | +-63.4% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02